|
|
|
Volumn 27, Issue 2 SUPPL. 3, 2000, Pages 24-29
|
|
Docetaxel (Taxotere) in hormone-refractory prostate cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
DEXAMETHASONE;
DOCETAXEL;
ESTRAMUSTINE;
ETOPOSIDE;
GEMCITABINE;
MITOXANTRONE;
NAVELBINE;
PACLITAXEL;
PROSTATE SPECIFIC ANTIGEN;
SURAMIN;
ANTINEOPLASTIC ACTIVITY;
CANCER ADJUVANT THERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE CALCULATION;
DRUG EFFICACY;
GRANULOCYTOPENIA;
HUMAN;
MALE;
NEUTROPENIA;
PRIORITY JOURNAL;
PROSTATE CANCER;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CLINICAL TRIALS;
DRUG RESISTANCE, NEOPLASM;
DRUG THERAPY, COMBINATION;
HUMANS;
MALE;
NEOPLASM RECURRENCE, LOCAL;
PACLITAXEL;
PROGNOSIS;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
TAXOIDS;
|
|
EID: 0034014822
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (56)
|
|
References (32)
|
